CC
CCM.US Concord Medical Services Holdings
- Market cap
- USD 15.7M
- P/E
- -
- P/B
- 3.00x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.
Is CCM.US undervalued?
Graham numberThe Graham number of Concord Medical Services Holdings cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Concord Medical Services Holdings fundamental analysis
No fundamental analysis for Concord Medical Services Holdings yet.
Concord Medical Services Holdings stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Concord Medical Services Holdings
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed t…
Full company profileConcord Medical Services Holdings financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Mar 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Concord Medical Services Holdings annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 455M | 331M | 191M | 198M | 223M | 486M | 472M | 537M | 384M | 461M | 1.02B |
| Gross Profit | 168M | 98.0M | 19.8M | -15.8M | 13.1M | -56.9M | -152M | -76.6M | -79.2M | 25.8M | 118M |
| Operating Income | -169M | -212M | -299M | -437M | -308M | -458M | -525M | -463M | -532M | -239M | -372M |
| EBITDA | 21.5M | -88.5M | -239M | -295M | -206M | -354M | -392M | -335M | -346M | -71.8M | -75.7M |
| Net Income | -262M | -284M | -235M | -307M | -404M | -271M | -490M | -298M | -308M | -92.8M | -258M |
| EPS | -1,804 | -1,967 | -1,625 | -2,122 | -9.25 | -1,864 | -3,363 | -2,044 | -2,117 | -637 | -1,782 |
| Balance Sheet | |||||||||||
| Total Assets | 3.23B | 3.47B | 4.59B | 4.30B | 5.33B | 6.23B | 6.00B | 6.05B | 6.73B | 6.55B | 6.55B |
| Total Liabilities | 2.00B | 2.45B | 2.31B | 2.41B | 2.93B | 3.49B | 3.99B | 4.31B | 5.11B | 4.70B | 4.70B |
| Shareholders' Equity | 1.17B | 934M | 437M | -123M | 2.40B | -1.37B | -1.86B | -2.12B | -2.28B | -2.10B | -2.10B |
| Cash & Short-term Investments | 190M | 98.2M | 455M | 74.3M | 334M | 157M | 158M | 58.1M | 351M | 298M | 298M |
| Total Debt | 1.19B | 1.24B | 938M | 1.52B | 2.35B | 2.73B | 3.24B | 3.30B | 3.93B | 3.63B | 3.63B |
| Cash Flow | |||||||||||
| Operating Cash Flow | -78.1M | 26.7M | -38.6M | -195M | -230M | -359M | -217M | -276M | -398M | -202M | - |
| Capital Expenditure | 118M | 289M | 764M | 701M | 513M | 761M | 384M | 116M | 411M | 91.3M | 0.00 |
| Free Cash Flow | -196M | -262M | -803M | -896M | -743M | -1.12B | -600M | -392M | -809M | -293M | - |
| Ratios | |||||||||||
| ROE | -22.5% | -30.4% | -53.7% | - | -16.8% | - | - | - | - | - | - |
| ROA | -8.1% | -8.2% | -5.1% | -7.1% | -7.6% | -4.4% | -8.2% | -4.9% | -4.6% | -1.4% | -3.9% |
| Net Profit Margin | -57.5% | -85.9% | -123.0% | -154.8% | -181.2% | -55.9% | -103.7% | -55.4% | -80.3% | -20.2% | -25.3% |
| Debt to Equity | 1.02x | 1.33x | 2.14x | - | 0.98x | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Concord Medical Services Holdings dividends
Concord Medical Services Holdings has not paid dividends in the last 9 fiscal years.
Last stock split: 1:10 on Jul 30, 2024.
Who owns Concord Medical Services Holdings
- Insiders 30.44%
- Institutions 2.81%
- Public & others 66.74%
- Shares outstanding 2.82M
- Free float 1.38M
Top funds holding CCM.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| NT Tax Advantaged BONY EM | 130.00 | 0.00% | 0.00% | Mar 2024 |
Top institutions holding CCM.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| SmartHarvest Portfolios, LLC | 13.9K | 0.32% | 0.00% | Jun 2026 |
| Susquehanna International Group, LLP | 11.1K | 0.25% | -5.58% | Jun 2026 |
| Citadel Advisors Llc | 10.5K | 0.24% | 0.00% | Jun 2026 |
| UBS Group AG | 500.00 | 0.01% | -18.70% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 100.00 | 0.00% | 0.00% | Jun 2026 |
| JONES FINANCIAL COMPANIES LLLP | 10.00 | 0.00% | 0.00% | Jun 2026 |
| SBI Securities Co Ltd | 4.00 | 0.00% | 0.00% | Jun 2026 |
Concord Medical Services Holdings company profile
- Company name
- Concord Medical Services Holdings
- Ticker
- CCM.US
- Exchange
- USA Stocks
- Listed since
- Dec 11, 2009
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 610
- Fiscal year end
- December
- Address
- East Zone, Hanwei Plaza, Beijing, China, 100020
- Phone
- 86 10 5903 6688
- Website
- concordmedical.com
About Concord Medical Services Holdings
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, and helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
Concord Medical Services Holdings management
4- Dr. Jianyu YangChairman & CEO · born 1971
- Mr. Botao ShiInterim Chief Financial Officer · born 1975
- Mr. Boxun ZhangChief Strategy Officer · born 1976
- Ms. Xun LiuFinancial Controller